Navigation Links
MediPurpose Sells 500 Millionth Safety Lancet to IMCO Member MMS Medical
Date:2/1/2008

NORCROSS, Ga., Feb. 1 /PRNewswire/ -- MediPurpose, an innovator in the medical device industry, has passed the 500 million mark for its industry- leading SurgiLance safety lancet. In recognition of this significant milestone, the company will hold a brief ceremony on Thursday, Feb. 21, at the offices of MMS Medical of St. Louis, Mo., the distributor who purchased the 500 millionth lancet.

"We want all our customers to share in this significant achievement and to know how much they are valued by the MediPurpose team. We are committed to continued innovation in healthcare." says CEO Patrick Yi.

Introduced in 2000, the SurgiLance safety lancet has found long-term success in all sectors of the healthcare market and has provided more than 500 million consumers with a safe, simple and effective tool for blood testing. MediPurpose currently offers six color-coded lancets, which are used for capillary blood sampling for a range of testing requirements.

To help the millions of children living with diabetes, MediPurpose will make a $1,000 donation to the Juvenile Diabetes Research Foundation in the name of MMS Medical. Chuck Berry, Walgreens District Manager, will accept the donation for JDRF. Berry is president of board for the Metro St. Louis / Greater Missouri chapter of JDRF. MMS Medical is a member of Independent Medical Co-Op (IMCO), a leading cooperative for medical supply distributors

"We are pleased that one of our members, MMS Medical, is being recognized by MediPurpose, a long-time valued supplier," says Deb Bullock, Vice President for IMCO. "We extend our congratulations to MediPurpose and its SurgiLance safety lancet on this significant achievement and look forward to continued growth together."

"We consider distributors like MMS Medical to be full partners in our success," says Randy Prather, MediPurpose VP of Sales and Marketing. "Since early 2001, MediPurpose has maintained a strong and vibrant relationship with IMCO and its member companies. They have grown into one of our most valued distribution partners." MMS Medical has purchased SurgiLance safety lancets since 2002.

"On behalf of MMS, we would like to congratulate MediPurpose on this sales milestone," says Kelly Hart, MMS Vice President Long Term Care. "We are honored to be a part of the celebration and look forward to our continued partnership to help improve the lives of those with diabetes."

About MediPurpose

MediPurpose develops, manufactures and markets innovative healthcare solutions valued by its customers. The company is known for introducing quality safety medical devices that protect healthcare professionals from sharps injury. Founded in 1999, the company achieved rapid success with its SurgiLance safety lancet, quickly becoming one of the top leaders in the US safety lancet market and establishing solid distribution channels worldwide.

MediPurpose maintains offices in the US, Singapore, the UK, France and Spain. As a globally recognized innovator, MediPurpose has developed a menu of services to assist inventors and growing medical device companies successfully design, patent, manufacture and sell their products.

For more information on MediPurpose, visit http://www.medipurpose.com.


'/>"/>
SOURCE MediPurpose
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. TeamStaff Sells Per Diem Business Unit
2. Turnaround Partners Sells Minority Ownership in Interactive Nutrition to Natural Nutrition
3. Informed Medical Communications Sells Consumer Internet Division to Revolution Health
4. Dragon Sells EPO Business; Focus on Antibiotic Core Business
5. NPS Sells Assets Related to mGluR Collaboration to AstraZeneca for $30 Million to Support Late-Stage Product Development
6. Celebrity Seating Only! Levitz Chair Signed by 39 Daytime Stars Sells for $1200 on Charitybuzz.com
7. OSHA Seeking Nominations for National Advisory Committee on Occupational Safety and Health
8. Using the safety belt in the rear seats of the car reduces death risk by almost a half
9. The American Society for Aesthetic Plastic Surgery Addresses the Safety of Botox
10. The Great Safety Adventure(R) Traveling Home Safety Exhibit Kicks Off Tenth Anniversary Tour
11. Debate over safety of gene therapy trials focuses on issue of informed consent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... The West Virginia ... 1, 2017. The name change aligns the entire company with its existing ... care quality. , “We are very proud of the achievements associated with the ...
(Date:12/8/2016)... Pennsylvania (PRWEB) , ... December 08, 2016 , ... ... Duck Donuts Franchising Company LLC, announced the first national #QuackGivesBack campaign which ... , “This was our first franchise-wide Quack Gives Back initiative, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has announced the ... and Eric Hoessel to vice president of sales. , Litsinger joined Mirixa ...
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , ... Greenberg Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont ... and attorneys from the firm’s global Life Sciences & Medical Technology Group have been ...
(Date:12/8/2016)... ... 08, 2016 , ... Launching of the ... Instance Manager architecture, meeting the needs of multichannel growth and doubling the ... auto-dialing system without agents, Presence Robodialer, provides greater operational capacity, administrative flexibility ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... -- KEY FINDINGS North America ... in 2016 and is expected to continue in the ... large number of surgical procedures that are taking place ... the patient temperature management market.) Patient warming and cooling ... blood during surgeries, lowering the risks of neurological disorders ...
(Date:12/8/2016)... Dec. 8, 2016  Eli Lilly and Company (NYSE: ... its phase 3 EXPEDITION3 trial at the 9 th ... previously disclosed, solanezumab did not meet the primary endpoint ... initiated in people with mild dementia due to Alzheimer,s ... for solanezumab for the treatment of mild dementia due ...
(Date:12/8/2016)... 8 de dezembro de 2016  A Mederi Therapeutics Inc . anunciou ... tratamento não cirúrgico para a doença do refluxo gastroesofágico (DRGE). Foto ... ... Live Stretta procedure performed and broadcast during the ... Wuhan Union Hospital ...
Breaking Medicine Technology: